Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.

Covera-HS sustained-release tablets (controlled onset)

Generic Name: verapamil (ver-AP-a-mil)
Brand Name: Covera-HS

Covera-HS sustained-release tablets (controlled onset) is used for:

Treating high blood pressure and chest pain. It may be used alone or with other medicines. It may also be used for certain conditions as determined by your doctor.

Covera-HS sustained-release tablets (controlled onset) is a calcium channel blocker. It works by relaxing (dilating) your blood vessels, lowering blood pressure, and decreasing heart rate, which lowers the workload on the heart. It also dilates coronary arteries, which increases blood flow to the heart.

Do NOT use Covera-HS sustained-release tablets (controlled onset) if:

  • you are allergic to any ingredient in Covera-HS sustained-release tablets (controlled onset)
  • you have certain heart problems (eg, left ventricular dysfunction, sick sinus syndrome, second- or third-degree heart block and do not have a pacemaker), very low blood pressure, or moderate to severe congestive heart failure (CHF)
  • you have atrial fibrillation or flutter and a pre-excitation syndrome (extra conduction pathway in the heart), such as Wolff-Parkinson-White (WPW) syndrome or Lown-Ganong-Levine (LGL) syndrome
  • you have shock caused by serious heart problems
  • you are taking dofetilide, or you have taken disopyramide within the past 48 hours

Contact your doctor or health care provider right away if any of these apply to you.

Before using Covera-HS sustained-release tablets (controlled onset):

Some medical conditions may interact with Covera-HS sustained-release tablets (controlled onset). Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

  • if you are pregnant, planning to become pregnant, or are breast-feeding
  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement
  • if you have allergies to medicines, foods, or other substances
  • if you have heart failure or a recent heart attack with lung congestion, low blood pressure, or heart problems (eg, a very slow heart rate, heart block, heart valve disease)
  • if you have kidney or liver problems, muscular dystrophy, or a neuromuscular disease
  • if you are taking another blood pressure medicine or you are being treated for cancer

Some MEDICINES MAY INTERACT with Covera-HS sustained-release tablets (controlled onset). Tell your health care provider if you are taking any other medicines, especially any of the following:

  • Beta-blockers (eg, propranolol), clonidine, disopyramide, ketolides (eg, telithromycin), macrolides (eg, erythromycin), or ritonavir because they may increase the risk of Covera-HS sustained-release tablets (controlled onset)'s side effects
  • Phenobarbital, rifampin, or St. John's wort because they may decrease Covera-HS sustained-release tablets (controlled onset)'s effectiveness
  • Aldosterone blockers (eg, eplerenone), aspirin, carbamazepine, colchicine, cyclosporine, digoxin, dofetilide, doxorubicin, dronedarone, eletriptan, erythromycin, everolimus, flecainide, HMG-CoA reductase inhibitors (eg, lovastatin, simvastatin), lithium, narcotic pain relievers (eg, fentanyl), paclitaxel, quinazolines (eg, terazosin), quinidine, ranolazine, theophyllines, or tolvaptan because the risk of their side effects may be increased by Covera-HS sustained-release tablets (controlled onset)

This may not be a complete list of all interactions that may occur. Ask your health care provider if Covera-HS sustained-release tablets (controlled onset) may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Covera-HS sustained-release tablets (controlled onset):

Use Covera-HS sustained-release tablets (controlled onset) as directed by your doctor. Check the label on the medicine for exact dosing instructions.

  • Take Covera-HS sustained-release tablets (controlled onset) by mouth with or without food.
  • Check with your doctor before you eat grapefruit or drink grapefruit juice while you use Covera-HS sustained-release tablets (controlled onset).
  • Swallow Covera-HS sustained-release tablets (controlled onset) whole. Do not break, crush, or chew before swallowing.
  • If you miss a dose of Covera-HS sustained-release tablets (controlled onset), take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Covera-HS sustained-release tablets (controlled onset).

Important safety information:

  • Covera-HS sustained-release tablets (controlled onset) may cause dizziness or lightheadedness. These effects may be worse if you take it with alcohol or certain medicines. Use Covera-HS sustained-release tablets (controlled onset) with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.
  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Covera-HS sustained-release tablets (controlled onset); it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.
  • Covera-HS sustained-release tablets (controlled onset) may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.
  • Patients who take medicine for high blood pressure often feel tired or run down for a few weeks after starting treatment. Be sure to take your medicine even if you may not feel "normal." Tell your doctor if you develop any new symptoms.
  • Tell your doctor or dentist that you take Covera-HS sustained-release tablets (controlled onset) before you receive any medical or dental care, emergency care, or surgery.
  • Lab tests, including liver function, kidney function, complete blood cell counts, and blood pressure, may be performed while you use Covera-HS sustained-release tablets (controlled onset). These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.
  • Use Covera-HS sustained-release tablets (controlled onset) with caution in the ELDERLY; they may be more sensitive to its effects.
  • Covera-HS sustained-release tablets (controlled onset) should not be used in CHILDREN; safety and effectiveness in children have not been confirmed.
  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Covera-HS sustained-release tablets (controlled onset) while you are pregnant. Covera-HS sustained-release tablets (controlled onset) is found in breast milk. If you are or will be breast-feeding while you use Covera-HS sustained-release tablets (controlled onset), check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Covera-HS sustained-release tablets (controlled onset):

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; dizziness; fatigue; headache; lightheadedness; nausea.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; fainting; lightheadedness, especially when standing; severe dizziness; shortness of breath; swelling of the feet or hands; symptoms of liver problems (eg, yellowing of the skin or eyes, dark urine, pale stools, severe or persistent stomach pain, fever, general feeling of being unwell); unusually fast, slow, or irregular heartbeat.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include decreased mental status; dizziness; loss of consciousness; shortness of breath; slow or irregular heartbeat.

Proper storage of Covera-HS sustained-release tablets (controlled onset):

Store Covera-HS sustained-release tablets (controlled onset) at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Covera-HS sustained-release tablets (controlled onset) out of the reach of children and away from pets.

General information:

  • If you have any questions about Covera-HS sustained-release tablets (controlled onset), please talk with your doctor, pharmacist, or other health care provider.
  • Covera-HS sustained-release tablets (controlled onset) is to be used only by the patient for whom it is prescribed. Do not share it with other people.
  • If your symptoms do not improve or if they become worse, check with your doctor.
  • Check with your pharmacist about how to dispose of unused medicine.

This information should not be used to decide whether or not to take Covera-HS sustained-release tablets (controlled onset) or any other medicine. Only your health care provider has the knowledge and training to decide which medicines are right for you. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about Covera-HS sustained-release tablets (controlled onset). It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to Covera-HS sustained-release tablets (controlled onset). This information is not specific medical advice and does not replace information you receive from your health care provider. You must talk with your healthcare provider for complete information about the risks and benefits of using Covera-HS sustained-release tablets (controlled onset).

Issue Date: June 3, 2015